We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

158 hedge funds and large institutions have $2.29B invested in Ironwood Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $17.8M | Put options by funds: $8.92M

50% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 18

6% more funds holding

Funds holding: 149 → 158 (+9)

4% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 49

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4.16% less ownership

Funds ownership: 138.95% → 134.79% (-4.2%)

8% less capital invested

Capital invested by funds: $2.48B → $2.29B (-$188M)

Holders
158
Holders Change
+9
Holders Change %
+6.04%
% of All Funds
3.58%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
51
Reduced
49
Closed
18
Calls
$17.8M
Puts
$8.92M
Net Calls
+$8.91M
Net Calls Change
+$6.47M

Top Buyers

Rank Fund Capital Flow
1
SCM
Sarissa Capital Management
Connecticut
+$25.7M
2
SAM
Senzar Asset Management
New York
+$14.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14.1M
4
PWAM
Park West Asset Management
California
+$9.57M
5
JP Morgan Chase
JP Morgan Chase
New York
+$6.66M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$44.5M
2
BM
Bridger Management
New York
-$40.2M
3
Deutsche Bank
Deutsche Bank
Germany
-$21.8M
4
O
OrbiMed
New York
-$19.2M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$15.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
151
Group One Trading
Illinois
$4K -$93.3K -7,146 -96%
Northwestern Mutual Wealth Management
152
Northwestern Mutual Wealth Management
Wisconsin
$4K – – –
AG
153
Advisor Group
Arizona
$3K -$1.29K -99 -31%
SPIA
154
Steward Partners Investment Advisory
New York
$3K – – –
GRP
155
Global Retirement Partners
California
$2K +$2.5K +191 New
ClearBridge Investments
156
ClearBridge Investments
New York
$1K -$31.4K -2,406 -96%
PMFA
157
Plante Moran Financial Advisors
Michigan
$1K – – –
DCM
158
Delpha Capital Management
New York
$1K +$1.48K +113 New
BI
159
BVF Inc
California
– -$44.5M -3,367,080 Closed
BM
160
Bridger Management
New York
– -$40.2M -3,040,037 Closed
FAM
161
Fred Alger Management
New York
– -$7.25M -549,193 Closed
NFA
162
Nationwide Fund Advisors
Ohio
– -$4.54M -343,719 Closed
HHC
163
Hutchin Hill Capital
New York
– -$2.92M -221,009 Closed
First Trust Advisors
164
First Trust Advisors
Illinois
– -$1.2M -90,639 Closed
IBT
165
International Biotechnology Trust
United Kingdom
– -$930K -70,446 Closed
GAM
166
Gotham Asset Management
New York
– -$541K -40,971 Closed
SG Americas Securities
167
SG Americas Securities
New York
– -$445K -33,655 Closed
Bank of Nova Scotia
168
Bank of Nova Scotia
Ontario, Canada
– -$299K -22,686 Closed
VWA
169
V Wealth Advisors
Kansas
– -$269K -19,792 Closed
Allianz Asset Management
170
Allianz Asset Management
Germany
– -$217K -16,459 Closed
PWP
171
Private Wealth Partners
California
– -$179K -13,588 Closed
Wolverine Trading
172
Wolverine Trading
Illinois
– -$175K -13,416 Closed
NSEDCP
173
NJ State Employees Deferred Compensation Plan
New Jersey
– -$158K -11,940 Closed
LWA
174
Lenox Wealth Advisors
New York
– -$3K -199 Closed
NFG
175
Next Financial Group
Texas
– -$2K -119 Closed
4 5 6
7
8

IRWD Hedge Fund Activity: Q4 2017 in Review

158 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2017, worth a combined $2.29B — down 7.6% from $2.48B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new IRWD positions and 18 closed out — a net gain of 9 holders — while 51 added to existing stakes and 49 trimmed.

The largest buyer was Sarissa Capital Management, opening a new position worth an estimated $25.7M. The largest seller was BVF Inc, exiting entirely with an estimated $44.5M sold.

  • 158 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2017, up from 149 in Q3 2017.
  • Funds reported $2.29B of Ironwood Pharmaceuticals stock for Q4 2017, down 7.6% quarter-over-quarter.
  • 27 funds opened new Ironwood Pharmaceuticals positions in Q4 2017 and 18 closed out, a net change of +9 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2017 was Sarissa Capital Management, an estimated $25.7M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2017 was BVF Inc, an estimated $44.5M sold.

Based on aggregated 13F filings for Q4 2017.